Recommended dairy product intake modulates circulating fatty acid profile in healthy adults: A multi-centre cross-over study

British Journal of Nutrition

Volumn 113, Issue 3, 2015, Pages 435-444

  Abdullah, Mohammad M H ^a,b   Cyr, Audrey ^c   Lépine, Marie Claude ^c   Labonté, Marie Ève ^c   Couture, Patrick ^c   Jones, Peter J H ^a,b   Lamarche, Benoît ^c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

CVD; Dairy products; Fatty acids; Lipids

Indexed keywords

FATTY ACID; HEPTADECANOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PENTADECANOIC ACID; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; LIPID; YOGHURT;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DAIRY PRODUCT; DIETARY COMPLIANCE; DIETARY REFERENCE INTAKE; FAT INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; FOOD INTAKE; FRAMINGHAM RISK SCORE; HUMAN; HUMAN EXPERIMENT; LIPID COMPOSITION; MALE; MULTICENTER STUDY; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; ANIMAL; BLOOD; CALORIC INTAKE; CHEESE; CLINICAL TRIAL; DIET; HEALTH CARE POLICY; MIDDLE AGED; MILK; NUTRITION; YOUNG ADULT;

ANACARDIUM OCCIDENTALE;

ADOLESCENT; ADULT; AGED; ANIMALS; BIOLOGICAL MARKERS; CHEESE; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DAIRY PRODUCTS; DIET; ENERGY INTAKE; FATTY ACIDS; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; MILK; NUTRITION POLICY; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; YOGURT; YOUNG ADULT;

EID: 84922613933     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514003894     Document Type: Article

References (58)

1. Health Canada (2007) Eating Well with Canada's Food Guide (HC Pub. 4651). Ottawa: Queen's Printer.
2. United States Department of Agriculture (2010) Dietary guidelines for Americans. http://www.cnpp.usda.gov/dietaryguidelines.htm (accessed February 2014).
3. Pereira MA, Jacobs DR Jr, Van Horn L, et al. (2002) Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA 287, 2081-2089.
4. Mirmiran P, Esmaillzadeh A & Azizi F (2005) Dairy consumption and body mass index: an inverse relationship. Int J Obes (Lond) 29, 115-121.
5. Azadbakht L, Mirmiran P, Esmaillzadeh A, et al. (2005) Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. Am J Clin Nutr 82, 523-530.
6. Elwood PC, Strain JJ, Robson PJ, et al. (2005) Milk consumption, stroke, and heart attack risk: evidence from the Caerphilly cohort of older men. J Epidemiol Community Health 59, 502-505.
7. Snijder MB, van Dam RM, Stehouwer CD, et al. (2008) A prospective study of dairy consumption in relation to changes in metabolic risk factors: the Hoorn Study. Obesity (Silver Spring) 16, 706-709.
8. Wennersberg MH, Smedman A, Turpeinen AM, et al. (2009) Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study. Am J Clin Nutr 90, 960-968.
9. Rideout TC, Marinangeli CP, Martin H, et al. (2013) Consumption of low-fat dairy foods for 6 months improves insulin resistance without adversely affecting lipids or body-weight in healthy adults: a randomized free-living cross-over study. Nutr J 12, 56.
10. Crichton GE, Howe PR, Buckley JD, et al. (2012) Dairy consumption and cardiometabolic health: outcomes of a 12-month crossover trial. Nutr Metab (Lond) 9, 19.
11. Jensen RG (2002) The composition of bovine milk lipids: January 1995 to December 2000. J Dairy Sci 85, 295-350.
12. Hunter JE, Zhang J & Kris-Etherton PM (2010) Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr 91, 46-63.
13. St-Onge MP & Bosarge A (2008) Weight-loss diet that includes consumption of medium-chain triacylglycerol oil leads to a greater rate of weight and fat mass loss than does olive oil. Am J Clin Nutr 87, 621-626.
14. Nosaka N, Maki H, Suzuki Y, et al. (2003) Effects of margarine containing medium-chain triacylglycerols on body fat reduction in humans. J Atheroscler Thromb 10, 290-298.
15. Chowdhury R, Warnakula S, Kunutsor S, et al. (2014) Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 160, 398-406.
16. Kris-Etherton PM, Pearson TA, Wan Y, et al. (1999) High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am J Clin Nutr 70, 1009-1015.
17. Teres S, Barcelo-Coblijn G, Benet M, et al. (2008) Oleic acid content is responsible for the reduction in blood pressure induced by olive oil. Proc Natl Acad Sci U S A 105, 13811-13816.
18. Smedman AE, Gustafsson IB, Berglund LG, et al. (1999) Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors. Am J Clin Nutr 69, 22-29.
19. Wolk A, Vessby B, Ljung H, et al. (1998) Evaluation of a biological marker of dairy fat intake. Am J Clin Nutr 68, 291-295.
20. Wolk A, Furuheim M & Vessby B (2001) Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men. J Nutr 131, 828-833.
21. Mozaffarian D, Cao H, King IB, et al. (2010) trans-Palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med 153, 790-799.
22. Biong AS, Veierod MB, Ringstad J, et al. (2006) Intake of milk fat, reflected in adipose tissue fatty acids and risk of myocardial infarction: a case-control study. Eur J Clin Nutr 60, 236-244.
23. Sun Q, Ma J, Campos H, et al. (2007) Plasma and erythrocyte biomarkers of dairy fat intake and risk of ischemic heart disease. Am J Clin Nutr 86, 929-937.
24. Warensjo E, Jansson JH, Cederholm T, et al. (2010) Biomarkers of milk fat and the risk of myocardial infarction in men and women: a prospective, matched case-control study. Am J Clin Nutr 92, 194-202.
25. Mozaffarian D, de Oliveira Otto MC, Lemaitre RN, et al. (2013) trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 97, 854-861.
26. Mozaffarian D, Cao H, King IB, et al. (2010) Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. Am J Clin Nutr 92, 1350-1358.
27. Labonte ME, Cyr A, Abdullah MM, et al. (2014) Dairy product consumption has no impact on biomarkers of inflammation among men and women with low-grade systemic inflammation. J Nutr 144, 1760-1767.
28. Ridker PM, Rifai N, Rose L, et al. (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347, 1557-1565.
29. Labonte ME, Cyr A, Baril-Gravel L, et al. (2012) Validity and reproducibility of a web-based, self-administered food frequency questionnaire. Eur J Clin Nutr 66, 166-173.
30. Bertrand KA, Giovannucci E, Liu Y, et al. (2012) Determinants of plasma 25-hydroxyvitamin D and development of prediction models in three US cohorts. Br J Nutr 108, 1889-1896.
31. Callaway CW, Chumlea WC, Bouchard C, et al. (1988) Standardization of anthropometric measurements. In The Airlie (VA) Consensus Conference, pp. 39-80 [T Lohman, A Roche and R Martorel, editors]. Champaign, IL: Human Kinetics Publishers.
32. Couillard C, Despres JP, Lamarche B, et al. (2001) Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol 21, 1226-1232.
33. Pirro M, Bergeron J, Dagenais GR, et al. (2001) Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch Intern Med 161, 2474-2480.
34. Friedewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499-502.
35. D'Agostino RB S, Vasan RS, Pencina MJ, et al. (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117, 743-753.
36. Folch J, Lees M & Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509.
37. O'Sullivan TA, Hafekost K, Mitrou F, et al. (2013) Food sources of saturated fat and the association with mortality: a meta-analysis. Am J Public Health 103, e31-e42.
38. de Oliveira Otto MC, Nettleton JA, Lemaitre RN, et al. (2013) Biomarkers of dairy fatty acids and risk of cardiovascular disease in the multi-ethnic study of atherosclerosis. J Am Heart Assoc 2, e000092.
39. Brevik A, Veierod MB, Drevon CA, et al. (2005) Evaluation of the odd fatty acids 15 : 0 and 17 : 0 in serum and adipose tissue as markers of intake of milk and dairy fat. Eur J Clin Nutr 59, 1417-1422.
40. Wennberg M, Vessby B & Johansson I (2009) Evaluation of relative intake of fatty acids according to the Northern Sweden FFQ with fatty acid levels in erythrocyte membranes as biomarkers. Public Health Nutr 12, 1477-1484.
41. Thiebaut AC, Rotival M, Gauthier E, et al. (2009) Correlation between serum phospholipid fatty acids and dietary intakes assessed a few years earlier. Nutr Cancer 61, 500-509.
42. Wu Z & Palmquist DL (1991) Synthesis and biohydrogenation of fatty acids by ruminal microorganisms in vitro. J Dairy Sci 74, 3035-3046.
43. Warensjo E, Nolan D & Tapsell L (2010) Dairy food consumption and obesity-related chronic disease. Adv Food Nutr Res 59, 1-41.
44. Nakamura MT & Nara TY (2004) Structure, function, and dietary regulation of Δ6, Δ5, and Δ9 desaturases. Annu Rev Nutr 24, 345-376.
45. Health Canada (2010) Canadian nutrient file, 2010 version. http://webprod3.hc-sc.gc.ca/cnf-fce/index-eng.jsp (accessed March 2014).
46. Jaudszus A, Kramer R, Pfeuffer M, et al. (2014) trans-Palmitoleic acid arises endogenously from dietary vaccenic acid. Am J Clin Nutr 99, 431-435.
47. Zlatanos SN, Laskaridis K & Sagredos A (2008) Conjugated linoleic acid content of human plasma. Lipids Health Dis 7, 34.
48. Papamandjaris AA, MacDougall DE & Jones PJ (1998) Medium chain fatty acid metabolism and energy expenditure: obesity treatment implications. Life Sci 62, 1203-1215.
49. Alexandrou E, Herzberg GR & White MD (2007) High-level medium-chain triglyceride feeding and energy expenditure in normal-weight women. Can J Physiol Pharmacol 85, 507-513.
50. St-Onge MP, Bourque C, Jones PJ, et al. (2003) Mediumversus long-chain triglycerides for 27 days increases fat oxidation and energy expenditure without resulting in changes in body composition in overweight women. Int J Obes Relat Metab Disord 27, 95-102.
51. St-Onge MP & Jones PJ (2003) Greater rise in fat oxidation with medium-chain triglyceride consumption relative to long-chain triglyceride is associated with lower initial body weight and greater loss of subcutaneous adipose tissue. Int J Obes Relat Metab Disord 27, 1565-1571.
52. Mukuddem-Petersen J, Stonehouse Oosthuizen W, Jerling JC, et al. (2007) Effects of a high walnut and high cashew nut diet on selected markers of the metabolic syndrome: a controlled feeding trial. Br J Nutr 97, 1144-1153.
53. Sabate J, Oda K & Ros E (2010) Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med 170, 821-827.
54. Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ: Lawrence Earlbaum Associates.
55. Da Silva MS & Rudkowska I (2014) Dairy products on metabolic health: current research and clinical implications. Maturitas 77, 221-228.
56. Elwood PC, Pickering JE, Hughes J, et al. (2004) Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies. Eur J Clin Nutr 58, 718-724.
57. Elwood PC, Givens DI, Beswick AD, et al. (2008) The survival advantage of milk and dairy consumption: an overview of evidence from cohort studies of vascular diseases, diabetes and cancer. J Am Coll Nutr 27, Suppl. 6, 723S-734S.
58. Elwood PC, Pickering JE, Givens DI, et al. (2010) The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids 45, 925-939.